Home » Topics » Articles » Insight

Insight
RSS

Deals With Non-Profit Groups Help Programs, Balance Sheet

Oct. 25, 1999

Resurrection Of Thalidomide Portends New Celgene Pipeline

Oct. 18, 1999

FDA Submissions, Approvals And Other Actions: September 1999

Oct. 18, 1999

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: September 1999

Oct. 18, 1999

Setbacks, Comebacks Are Part Of Biotech's Changing Portrait

Oct. 11, 1999

No HIV Breakthroughs, But Good Data At ICAAC

Oct. 11, 1999

Clinical Trial Update: September 1999

Oct. 11, 1999

Biotechs Attempt Offerings Following Summer Rally

Oct. 4, 1999

Other Financings Of Public Biotechnology Companies: September 1999

Oct. 4, 1999

Venture Capital, PIPE/Reg. S And Corporate Investments In Biotechnology Companies: September 1999

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Selection Therapeutics identifies new Kv1.3 blockers
BioWorld Science
Selection Therapeutics GmbH has discovered new potassium voltage-gated channel subfamily A member 3 (KCNA3; Kv1.3) blockers potentially useful for the treatment...
Ignis Therapeutics synthesizes new muscarinic M4 receptor PAMs
BioWorld Science
Ignis Therapeutics (Suzhou) Co. Ltd. has patented new muscarinic M4 receptor positive allosteric modulators (PAMs) potentially useful for the treatment of...